Multi-omics Characterization of Improved Cognitive Functions in Parkinson's Disease Patients after the Combined Metabolic Activator Treatment: a Randomized, Double-Blinded, Placebo-Controlled Phase II Trial.
BRAIN COMMUNICATIONS(2025)
Key words
Parkinson's disease,combined metabolic activators,systems biology,multi-omics
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined